Net Cash Provided by (Used in) Operating Activities |
-10.3M |
USD |
-133% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
15.3M |
USD |
|
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
250M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
23.1M |
shares |
+6.84% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
4.97M |
USD |
|
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
20.1M |
USD |
+53.4% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
998K |
USD |
+176% |
Q1 2025 |
Q1 2025 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
233M |
USD |
+5.57% |
Q2 2025 |
Q2 2025 |
Interest Expense |
219K |
USD |
|
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |